Information Provided By:
Fly News Breaks for March 2, 2015
ROVI
Mar 2, 2015 | 08:12 EDT
Brean Capital noted recent reports that an activist investor had taken interest in Rovi and thinks the investors desire to either see the company sold to private equity or to see Rovi separate its licensing business from its products business. Brean Capital believes Rovi shares would have outperformed in 2015, but that the activist interest may accelerate that outperformance. Brean Capital maintained its Buy rating and $31 price target on Rovi Shares.
News For ROVI From the Last 2 Days
There are no results for your query ROVI
I agree to the thefly.com's disclaimer & terms of use
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.